Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Teva Pharmaceutical
Pharma
Teva forecasts $5B-plus in innovative drug sales by 2030
By 2030, Teva now expects to achieve at least $5 billion in innovative medicine sales, driven largely by Austedo, Ajovy and Uzedy.
Fraiser Kansteiner
May 30, 2025 7:20am
Teva plots layoffs as restructuring drive enters new phase
May 8, 2025 9:55am
Teva's subdued outlook puts damper on strong 2024 results
Jan 29, 2025 1:13pm
Teva's Copaxone gets boxed warning for anaphylaxis risk
Jan 23, 2025 7:52am
Teva, Takeda divest generics joint venture in Japan
Dec 6, 2024 10:53am
Teva hit with €463M fine over Copaxone misconduct claims in EU
Oct 31, 2024 10:45am
